Evidence map›Paper›PMID 39493175›Full record

ArticleCureus2024

Reviewing the Raters: A Study of Orthopedic Oncology Rating Outcomes During COVID-19.

Megna Panchbhavi, Alexander Yu, Jie Chen, John C Hagedorn, Cory Janney, Daniel Jupiter

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Megna PanchbhaviDepartment of Applied Computational Statistics and Mathematics, University of Notre Dame, Indiana, USA.
Alexander YuSchool of Medicine, University of Texas Medical Branch, Galveston, USA.
Jie ChenDepartment of Orthopedic Surgery and Rehabilitation, University of Texas Medical Branch, Galveston, USA.
John C HagedornDepartment of Orthopedic Surgery and Rehabilitation, University of Texas Medical Branch, Galveston, USA.
Cory JanneyDepartment of Orthopedic Surgery, Naval Medical Center San Diego, San Diego, USA.
Daniel JupiterDepartment of Preventive Medicine and Community Health, University of Texas Medical Branch, Galveston, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background During the 2020 COVID outbreak, telemedicine usage rates skyrocketed. We investigated the effect of telemedicine availability and demographic factors on orthopedic oncologist ratings and review rates. We also investigated patient-reported positive and negative experiences on www.heathgrades.com to determine which physician interaction factors were more importantly perceived by patients. Methods All orthopedic oncologists (n = 141) on www.healthgrades.com were selected for review through October 2020. Information obtained included telemedicine availability, gender, age, location of practice, review rate (number of reviews per 1000 days), mean star rating, and patient-reported positive and negative physician interactions. Mean star ratings and number of ratings were compared with respect to demographic information and telemedicine availability. Mean star ratings and review rates of orthopedic oncologists offering telemedicine were compared before and after January 01, 2020. Patients perceived positive and negative physician interaction factors were reported as a frequency of pooled positive or negative interaction factors, respectively. Results There were no significant differences in mean star rating or review rate with respect to demographic factors, telemedicine availability, or telemedicine offering orthopedic oncologists before and after January 01, 2020. There were increased positive interactions of both physician independent and dependent factors and increased negative interactions of time dependent factors. Conclusion Patients reported an increased frequency of negatively perceived wait times and rushed appointments. Telemedicine availability has been previously cited as a cost-effective means of reducing wait times. Prospective investigations are needed to determine if telemedicine can be utilized as a cost-effective means of improving patient care and satisfaction.

Indexed as

covidoncologyorthopedicoutcomesratingtelemedicine

Identifiers

PMID39493175
PMCPMC11531921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.